Daiichi Sankyō (4568.T) Financial Analysis & Valuation | Quarter Chart

Daiichi Sankyō (4568.T)

4568.T
Price: $16.86
Fair Value: 🔒
🔒score
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for... more
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells p... more
Description Shares
Market Cap$30.68BExchangeJPX
SectorHealthcareIndustryDrug Manufacturers - General
CountryJPCEOHiroyuki Okuzawa
IPO Date2000-01-04CAGR0.05%
Employees18,726Websitewww.daiichisankyo.com
Div. Yield2.94%Payout Ratio0.42%
Buy Back Yield2.34%Total Yield5.28%
4568.T chart loading...
Fundamentals Technicals
Enterprise Value$5956.45BP/E Ratio18.84
Forward P/E—PEG Ratio-0.39
P/S Ratio2.35P/B Ratio2.87
P/CF Ratio39.59P/FCF Ratio-458.94
EPS$0.94EPS Growth 1Y26.92%
EPS Growth 3Y428.47%EPS Growth 5Y351.08%
Revenue Growth 1Y14.26%Gross Margin0.78%
Operating Margin0.14%Profit Margin0.15%
ROE0.19%ROA0.08%
ROCE0.09%Current Ratio2.69
Quick Ratio1.85Cash Ratio0.7
Debt/Equity0.18Interest Coverage24.8
Altman Z Score3.15Piotroski Score6

View Daiichi Sankyō financial charts →